Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05229432 · ClinicalTrials.gov registry record
Study of Gastric Motility in Eosinophilic Gastritis
A clinical trial of Gastroparesis and Eosinophilic Gastritis, sponsored by Children's Hospital Medical Center, Cincinnati.
- Recruiting
- Registry status
- 30
- Enrollment target
- 3
- Study locations
NCT05229432: Recruiting study of Gastroparesis and Eosinophilic Gastritis, sponsored by Children's Hospital Medical Center, Cincinnati.
NCT05229432 is a study of Gastroparesis and Eosinophilic Gastritis that is actively recruiting participants, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 30 participants, below the 301-participant average among 44 other Gastroparesis trials with a reported enrollment target (90% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05229432, a study of Gastroparesis and Eosinophilic Gastritis, is actively recruiting participants, sponsored by Children's Hospital Medical Center, Cincinnati.
- RECRUITING
- Registry status
- 30 participants
- Enrollment target
- 3
- Study locations
Study Summary
Purpose: The study is a cross-sectional observational study designed to determine if eosinophilic gastritis (EG) results in gastric motility impairment. Hypothesis: Gastric dysfunction occurs in the natural history of EG but is underdiagnosed due, in part, to contraindications to the use of the standard meals used in gastric emptying studies.
Primary Outcome
A gastric motility disorder will be defined as the presence of delayed gastric emptying ( \> 8% of an oatmeal meal remaining in the stomach at 3 hours) measured by gastric emptying scintigraphy (GES). Specifically, the participant will consume oatmeal with a small amount of mixed-in radioactive material. After consuming the meal, a gastric emptying scintigraphy scan will take images at the following timepoints: 0 minutes, 30 minutes, 60 minutes, 120 minutes and 180 minutes.
Conditions Studied
Study Locations (3)
Illinois
- Northwestern University - Chicago
Maryland
- The National Institutes of Health - Bethesda
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-01-25 |
| Est. Completion | 2026-12-01 |
What NCT05229432 shows while recruiting
NCT05229432 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 301-participant average among 44 other Gastroparesis trials with a reported enrollment target (90% lower).
The record links to 3 conditions, with Gastroparesis appearing as the primary indexed condition, and to 0 interventions.
NCT05229432 reports a single indexed study location in Illinois, Maryland, Utah.
Frequently Asked Questions
What is clinical trial NCT05229432 about?
NCT05229432 is a clinical study titled "Study of Gastric Motility in Eosinophilic Gastritis". Purpose: The study is a cross-sectional observational study designed to determine if eosinophilic gastritis (EG) results in gastric motility impairment. Hypothesis: Gastric dysfunction occurs in the natural history of EG but is underdiagnosed due, in part, to contraindications to the use of the s...
What is the current status of trial NCT05229432?
This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2023-01-25. Estimated completion is 2026-12-01.
What conditions does trial NCT05229432 study?
This clinical trial studies the following conditions: Gastroparesis, Eosinophilic Gastritis, Gastric Motility Disorder.
Who is sponsoring clinical trial NCT05229432?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05229432 being conducted?
This trial has 3 study locations across Illinois, Maryland, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastroparesis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05229432's enrollment target sits among peer trials
30 30th of 44 higher than 15 of 44 other Gastroparesis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gastroparesis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Gastroparesis Registry 4
RECRUITING
-
The Use of Body Surface Gastric Mapping in Assessing the Clinical Success of G-POEM
RECRUITING · NA
-
Indiana University Gastrointestinal Motility Diagnosis Registry
RECRUITING
-
Compassionate Use of Domperidone for Refractory Gastroparesis
RECRUITING · NA
-
Central and Peripheral Effects of Cognitive Behavioral Therapy on Brain-Gut Axis Signaling in Gastroparetic Patients
RECRUITING · NA
-
Gastroparesis Outcome Longitudinal Database Enrolled Numerically
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI